Back to Search Start Over

The LRRK2 p.L1795F variant causes Parkinson's disease in the European population.

Authors :
Lange LM
Levine K
Fox SH
Marras C
Ahmed N
Kuznetsov N
Vitale D
Iwaki H
Lohmann K
Marsili L
Espay AJ
Bauer P
Beetz C
Martin J
Factor SA
Higginbotham LA
Chen H
Leonard H
Nalls M
Mencacci NE
Morris HR
Klein C
Blauwendraat C
Fang ZH
Source :
Research square [Res Sq] 2024 Sep 20. Date of Electronic Publication: 2024 Sep 20.
Publication Year :
2024

Abstract

Pathogenic variants in the LRRK2 gene represent the most common cause of autosomal dominant Parkinson's disease (PD) worldwide. We identified the LRRK2 p.L1795F variant in 14 White/European ancestry PD patients, including two families with multiple affected carriers and seven additional affected individuals with familial PD using genotyping and sequencing data from more than 50,000 individuals through GP2, AMP-PD, PDGENEration, and CENTOGENE. All variant carriers were of White/European ancestry, and those with available genotyping data shared a common haplotype. The clinical presentation of p.L1795F carriers resembles that of other LRRK2 pathogenic variant carriers. Combined with published functional evidence showing strongly enhanced LRRK2 kinase activity, our findings provide conclusive evidence that the LRRK2 p.L1795F variant is pathogenic. It represents a rare cause of PD in the European population but needs to be included in genetic testing efforts and considered for ongoing gene-specific clinical trials.<br />Competing Interests: Competing interests L.M.L., N.A., K. Lo., and L.A.H. declare no competing interests.

Details

Language :
English
ISSN :
2693-5015
Database :
MEDLINE
Journal :
Research square
Publication Type :
Academic Journal
Accession number :
39372927
Full Text :
https://doi.org/10.21203/rs.3.rs-4772543/v1